Development of OX40 agonists for canine cancer immunotherapy

Development of OX40 agonists for canine cancer immunotherapy

Summary: Recent breakthroughs in cancer immunotherapy have provided unprecedented clinical benefits to human cancer patients. Cancer is also one of the most common causes of death in pet dogs. Thus, canine-specific immune therapies targeting similar signaling pathways can provide better treatment op...

Full description

Bibliographic Details
Main Authors: Damien Ruiz, Chloe Haynes, Jonathan Marable, Chetan Pundkar, Rebecca L. Nance, Deepa Bedi, Payal Agarwal, Amol S. Suryawanshi, Amarjit Mishra, Bruce F. Smith, Maninder Sandey
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:iScience
Subjects:
Biological sciences
systems biology
cancer systems biology
cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222014304

Internet

http://www.sciencedirect.com/science/article/pii/S2589004222014304

Similar Items